New Covenant Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
1,238
+69
+6% +$70.5K 1.12% 19
2026
Q1
$1.08M Buy
1,169
+118
+11% +$120K 0.96% 23
2025
Q4
$1.14M Buy
1,051
+12
+1% +$11.5K 1.02% 21
2025
Q3
$793K Sell
1,039
-1,499
-59% -$1.12M 0.74% 29
2025
Q2
$1.97M Sell
2,538
-405
-14% -$315K 1.76% 14
2025
Q1
$2.42M Sell
2,943
-68
-2% -$56.6K 2.56% 10
2024
Q4
$2.33M Sell
3,011
-192
-6% -$159K 2.31% 12
2024
Q3
$2.81M Buy
3,203
+170
+6% +$153K 2.72% 10
2024
Q2
$2.6M Sell
3,033
-245
-7% -$196K 2.99% 10
2024
Q1
$2.55M Buy
+3,278
New +$2.33M 2.55% 10

Other funds holding LLY

New Covenant Trust Company's LLY Position: Q2 2026 in Review

New Covenant Trust Company increased its Eli Lilly (LLY) stake by 5.9% in Q2 2026, buying an estimated $70.5K and bringing the position to 1,238 shares worth $1.48M. The position accounts for 1.12% of the portfolio, ranked #19.

New Covenant Trust Company first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.81M in Q3 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • New Covenant Trust Company held 1,238 shares of Eli Lilly worth $1.48M as of Q2 2026.
  • New Covenant Trust Company bought 69 Eli Lilly shares in Q2 2026, an estimated $70.5K.
  • Eli Lilly made up 1.12% of New Covenant Trust Company's portfolio in Q2 2026, its #19 holding.
  • New Covenant Trust Company first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • New Covenant Trust Company's Eli Lilly position peaked at $2.81M in Q3 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on New Covenant Trust Company's 13F filing for Q2 2026, filed 14 Jul 2026.